{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:14:30Z","timestamp":1768457670418,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273853"],"award-info":[{"award-number":["82273853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073765"],"award-info":[{"award-number":["82073765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejmech.2024.116643","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T06:58:38Z","timestamp":1719989918000},"page":"116643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Discovery of N\u2032-benzyl-3-chloro-N-((1S,3R,4R)-3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)cyclohexyl)benzenesulfonamide as a novel selective KOR ligand"],"prefix":"10.1016","volume":"276","author":[{"given":"Yang","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lunan","family":"lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116643_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/bja\/81.1.12","article-title":"Molecular mechanisms of opioid receptor signal transduction","volume":"81","author":"Jordan","year":"1998","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejmech.2024.116643_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/383819a0","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene","volume":"383","author":"Matthes","year":"1996","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2024.116643_bib3","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1111\/pme.12911","article-title":"Opioid-induced constipation","volume":"16","author":"Webster","year":"2015","journal-title":"Pain Med."},{"key":"10.1016\/j.ejmech.2024.116643_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2024.116643_bib5","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.36076\/ppj.2017.s109","article-title":"Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: Part 1","volume":"20","author":"Kaye","year":"2017","journal-title":"Pain Physician"},{"key":"10.1016\/j.ejmech.2024.116643_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2003-36558","article-title":"[Development of opioid tolerance - molecular mechanisms and clinical consequences]","volume":"38","author":"Freye","year":"2003","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"10.1016\/j.ejmech.2024.116643_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/ALN.0000000000000963","article-title":"Differential opioid tolerance and opioid-induced hyperalgesia: a clinical reality","volume":"124","author":"Hayhurst","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2024.116643_bib8","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/aps.2010.138","article-title":"The role of kappa-opioid receptor activation in mediating antinociception and addiction","volume":"31","author":"Wang","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2024.116643_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1208\/s12248-009-9105-4","article-title":"Peptide kappa opioid receptor ligands: potential for drug development","volume":"11","author":"Aldrich","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.ejmech.2024.116643_bib10","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116643_bib11","first-page":"413","article-title":"Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects","volume":"242","author":"Dykstra","year":"1987","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116643_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","article-title":"Dynorphin, stress, and depression","volume":"1314","author":"Knoll","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2024.116643_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-2999(01)01588-6","article-title":"Antipruritic activity of the kappa-opioid receptor agonist, TRK-820","volume":"435","author":"Togashi","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116643_bib14","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1021\/bi900605n","article-title":"Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor","volume":"48","author":"Yan","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2024.116643_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/mol.113.089649","article-title":"Identification of novel functionally selective kappa-opioid receptor scaffolds","volume":"85","author":"White","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116643_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/jpet.114.216820","article-title":"The G protein-biased kappa-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo","volume":"352","author":"White","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116643_bib17","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1021\/jm500940q","article-title":"Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted kappa-opioid receptor agonists","volume":"57","author":"Bourgeois","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116643_bib18","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1016\/j.bmc.2014.04.054","article-title":"Combination of cyclohexane and piperazine based kappa-opioid receptor agonists: synthesis and pharmacological evaluation of trans,trans-configured perhydroquinoxalines","volume":"22","author":"Bourgeois","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116643_bib19","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1016\/j.bmcl.2015.09.040","article-title":"Conformationally restricted kappa-opioid receptor agonists: synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines","volume":"25","author":"Molenveld","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116643_bib20","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1021\/acs.jmedchem.6b01868","article-title":"Design and synthesis of enantiomerically pure decahydroquinoxalines as potent and selective kappa-opioid receptor agonists with anti-inflammatory activity in vivo","volume":"60","author":"Soeberdt","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116643_bib21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1248\/cpb.c17-00555","article-title":"Discovery of peripheral kappa-opioid receptor agonists as novel analgesics","volume":"65","author":"Suzuki","year":"2017","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejmech.2024.116643_bib22","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.bmcl.2017.06.017","article-title":"Discovery of highly selective kappa-opioid receptor agonists: 10alpha-Hydroxy TRK-820 derivatives","volume":"27","author":"Suzuki","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116643_bib23","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.1021\/acs.jmedchem.9b00857","article-title":"Discovery of a highly selective and potent kappa opioid receptor agonist from N-Cyclopropylmethyl-7alpha-phenyl-6,14-endoethanotetrahydronorthebaines with reduced central nervous system (CNS) side effects navigated by the message-address concept","volume":"62","author":"Xiao","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116643_bib24","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1021\/acs.jmedchem.1c01082","article-title":"Discovery of an M-substituted N-Cyclopropylmethyl-7alpha-phenyl-6,14-endoethanotetrahydronorthebaine as a selective, potent, and orally active kappa-opioid receptor agonist with an improved central nervous system safety profile","volume":"64","author":"He","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116643_bib25","doi-asserted-by":"crossref","first-page":"10377","DOI":"10.1021\/acs.jmedchem.2c00014","article-title":"SLL-627 is a highly selective and potent kappa opioid receptor (KOR) agonist with an unexpected nonreduction in locomotor activity","volume":"65","author":"Kong","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116643_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11094-016-1388-z","article-title":"Opioid \u03ba receptors as a molecular target for the creation of a new generation of analgesic drugs","volume":"50","author":"Grechko","year":"2016","journal-title":"Pharmaceut. Chem. J."},{"issue":"Suppl 10","key":"10.1016\/j.ejmech.2024.116643_bib27","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/AJP.0b013e3181c49e3a","article-title":"Delta and kappa opioid receptors as suitable drug targets for pain","volume":"26","author":"Vanderah","year":"2010","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.ejmech.2024.116643_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s11094-018-1703-y","article-title":"Prospects of a search for kappa-opioid receptor agonists with analgesic activity","volume":"51","author":"Zaitseva","year":"2018","journal-title":"Pharmaceut. Chem. J."},{"key":"10.1016\/j.ejmech.2024.116643_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acschemneuro.0c00487","article-title":"Design, synthesis, and structure-activity relationship exploration of alkyl\/phenylalkyl piperidine analogues as novel highly potent and selective mu opioid receptor agonists","volume":"12","author":"Huang","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116643_bib30","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1021\/acs.jmedchem.1c00722","article-title":"Discovery, structure-activity relationship, and mechanistic studies of 1-((3R,4S)-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a novel potent analgesic","volume":"64","author":"Huang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116643_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424005233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424005233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:48:07Z","timestamp":1730738887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424005233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":31,"alternative-id":["S0223523424005233"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116643","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of N\u2032-benzyl-3-chloro-N-((1S,3R,4R)-3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)cyclohexyl)benzenesulfonamide as a novel selective KOR ligand","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116643"}}